Loading NVO charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading NVO comparable companies…
| NVONovo Nordisk A S(opens in a new tab) | — | $46.82B | +11.1% | 81.0% | 41.3% | — | — |
|---|---|---|---|---|---|---|---|
| LLYEli Lilly and Co.(opens in a new tab) | $1.27T | $86.46B | +45.5% | 83.6% | — | 14.64× | 46.0× |
| AZNAstrazeneca plc(opens in a new tab) | — | $58.74B | +8.6% | 81.9% | 23.4% | — | — |
| SNYSanofi(opens in a new tab) | $54.38B | — | — | — | — | — | 6.2× |
| NVSNovartis AG(opens in a new tab) | $314.36B | — | — | — | — | — | — |
| Medianpeers, excl. NVO | $314.36B | $72.60B | +27.1% | 82.8% | 23.4% | 14.64× | 26.1× |